Patent details

Basic Information

Publication number:

EP3169361

PCT Application Number:

US2015040582

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157476474

PCT Publication Number:

WO2016011160

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPOSITIONS FOR TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS

French Title of Invention:

COMPOSITIONS DE TRAITEMENT DU CANCER À L'AIDE D'ANTAGONISTES DE LIAISON À L'AXE PD-1 ET D'INHIBITEURS DE MEK

German Title of Invention:

ZUSAMMENSETZUNGEN ZUR KREBSBEHANDLUNG MIT PD-1-ACHSENBINDENDEN ANTAGONISTEN UND MEK-INHIBITOREN

SPC Number:

Dates

Filing date:

15/07/2015

Grant date:

19/06/2019

EP Publication Date:

24/05/2017

PCT Publication Date:

21/01/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/06/2019

EP B1 Publication Date:

19/06/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

15/07/2019

Expiration date:

15/07/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/06/2019

 

 

Name:

F. Hoffmann-La Roche AG

Address:

Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Inventor

Name:

JUNTTILA, Melissa

Address:

United States (US)

Priority

Priority Number:

201462024988 P

Priority Date:

15/07/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/395; A61P 35/00; C07K 16/28;

Publication

European Patent Bulletin

Issue number:

201925

Publication date:

19/06/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages